+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Infectious Disease Diagnostic Market - Global Forecast 2026-2032- Product Image
Infectious Disease Diagnostic Market - Global Forecast 2026-2032- Product Image
New

Infectious Disease Diagnostic Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 186 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4829907
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The infectious disease diagnostic market is undergoing notable change, highlighted by accelerating technology adoption and adaptive approaches across healthcare organizations. As global demand rises for responsive, data-driven diagnostics, industry leaders are prioritizing accuracy, speed, and scalable integration within clinical environments.

Market Snapshot: Infectious Disease Diagnostic Market Growth and Outlook

In recent years, the Infectious Disease Diagnostic Market has expanded from USD 27.06 billion in 2025 to USD 29.41 billion in 2026, reflecting a compound annual growth rate (CAGR) of 8.93%. Projections suggest it will reach USD 49.28 billion by 2032, underscoring the sector's ongoing momentum. This growth is attributed to continuous investments and technological advances, alongside changing models of healthcare delivery and intensified focus on operational resilience. Decision-makers face evolving opportunities and challenges as value propositions realign, operational models adapt, and regional market dynamics shift within the broader health technology landscape.

Scope & Segmentation: Mapping the Infectious Disease Diagnostic Ecosystem

This comprehensive market research provides segmented analysis, covering core component categories, use environments, technology integration, and geographic spread integral to the infectious disease diagnostic landscape.

  • Product Platforms: Advanced diagnostic instruments including immunoassay analyzers, mass spectrometers, microarray platforms, and PCR systems; purpose-designed reagents and kits such as antigen detection assays, ELISA kits, immunoassay kits, and PCR kits; and specialized software supporting analytics and laboratory workflow optimization.
  • Sample Matrices: Blood-based samples (plasma, serum, whole blood), multiple swab types (nasal, rectal, throat), stool, and urine—enabling flexible diagnostic application in laboratory, research, and point-of-care contexts.
  • Testing Modalities: Centralized lab testing and point-of-care solutions, each selected for context-dependent efficiency, resource planning, and turnaround time.
  • Pathogen Classifications: Broad focus on bacterial, viral, fungal, and parasitic agents; dedicated emphasis on clinically significant viral infections such as hepatitis, HIV, and influenza for infection management and epidemiological monitoring.
  • Disease Indications: Comprehensive evaluation of diagnostics for key bacterial (meningitis, tuberculosis), fungal (aspergillosis, candidiasis, cryptococcosis), parasitic (leishmaniasis, malaria, schistosomiasis), vector-borne (dengue, Lyme disease, Zika), and viral (various hepatitis strains, HIV/AIDS, influenza) conditions.
  • End-User Environments: Coverage of academic and research institutes, diagnostic laboratories, hospitals, and clinical settings, addressing adoption drivers such as workflow specialization and regulatory needs.
  • Regional Coverage: Americas, Europe, Middle East, Africa, and Asia-Pacific, each reflecting differing levels of health system maturity, regulatory drivers, and opportunities for market advancement.

Key Takeaways for Senior Decision-Makers

  • Integration of molecular biology with artificial intelligence is improving diagnostic reliability and operational efficiency within diverse care settings, paving the way for scalable clinical applications.
  • Digital advancements, such as cloud-based data sharing and real-time result delivery, enhance accessibility and support consistent quality across decentralized and resource-limited facilities.
  • Collaboration among instrument manufacturers, reagent suppliers, and software developers is accelerating deployment of market-ready solutions, supporting faster response to emerging health crises.
  • Diversified supply chain strategies and expanded sourcing networks are crucial for organizations to minimize disruption and promote operational continuity within complex healthcare landscapes.
  • Segment-based approaches enable organizations to customize their solutions to specific stakeholder needs, amplifying impact and enabling deeper regional and operational penetration within the sector.
  • Business resilience is increasingly tied to flexibility in commercial models and proactive management of regulatory and supply chain risks within a changing policy environment.

Tariff Impact: Navigating United States Tariff Pressures on Diagnostic Markets

Recent tariffs imposed in the United States have shifted cost structures for imported diagnostic components and equipment. Organizations are responding by ramping up domestic production, broadening supplier partnerships, and redesigning sourcing contracts. These adaptive strategies are now integral aspects of company decision-making and collaborative frameworks within the diagnostics supply chain.

Methodology & Data Sources

Findings in this report derive from direct interviews with industry executives, technical experts, and regulatory authorities, in addition to peer-reviewed research and validated industry publications. Robust triangulation and scenario analysis were used to ensure reliability and relevance across all insights.

Why This Report Matters: Strategic Decision Support in the Infectious Disease Diagnostic Market

  • Equip your leadership with practical insights on technology adoption, emerging regulations, and actionable market opportunities to refine operational and resource planning.
  • Enhance competitive strategy using comprehensive segmentation, detailed end-user profiling, and region-specific perspectives tailored to evolving market conditions.
  • Strengthen continuity and risk management initiatives by anticipating policy changes and understanding tariff-driven operational adjustments affecting the global diagnostics value chain.

Conclusion

Technological advancement and cross-sector partnerships provide a foundation for informed, resilient strategies within the infectious disease diagnostic market. This analysis supports stakeholders in addressing emerging healthcare challenges and sustaining market growth.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Infectious Disease Diagnostic Market, by Product
8.1. Instruments
8.1.1. Immunoassay Analyzers
8.1.2. Mass Spectrometers
8.1.3. Microarrays
8.1.4. PCR Systems
8.2. Reagents & Kits
8.2.1. Antigen Detection Kits
8.2.2. ELISA Kits
8.2.3. Immunoassay Kits
8.2.4. PCR Kits
8.3. Software
9. Infectious Disease Diagnostic Market, by Sample Type
9.1. Blood
9.2. Stool
9.3. Swab
9.3.1. Nasal
9.3.2. Rectal
9.3.3. Throat
9.4. Urine
10. Infectious Disease Diagnostic Market, by Testing Type
10.1. Laboratory Testing
10.2. PoC Testing
11. Infectious Disease Diagnostic Market, by Pathogen Type
11.1. Bacterial
11.2. Fungal
11.3. Parasitic
11.4. Viral
11.4.1. Hepatitis
11.4.2. HIV
11.4.3. Influenza
12. Infectious Disease Diagnostic Market, by Disease Type
12.1. Bacterial Infectious Diseases
12.1.1. Meningitis
12.1.2. Pneumonia
12.1.3. Tuberculosis
12.2. Fungal Infections
12.2.1. Aspergillosis
12.2.2. Candidiasis
12.2.3. Cryptococcosis
12.3. Parasitic Infections
12.3.1. Leishmaniasis
12.3.2. Malaria
12.3.3. Schistosomiasis
12.4. Vector-borne Infections
12.4.1. Dengue Fever
12.4.2. Lyme Disease
12.4.3. Zika Virus
12.5. Viral Infectious Diseases
12.5.1. Hepatitis (A, B, C)
12.5.2. Hepatitis B & C
12.5.3. HIV/AIDS
12.5.4. Influenza
13. Infectious Disease Diagnostic Market, by End-User
13.1. Academic & Research Institutes
13.2. Diagnostic Laboratories
13.3. Hospitals & Clinics
14. Infectious Disease Diagnostic Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Infectious Disease Diagnostic Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Infectious Disease Diagnostic Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Infectious Disease Diagnostic Market
18. China Infectious Disease Diagnostic Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Abbott Laboratories
19.6. Adaptive Biotechnologies Corporation
19.7. Agilent Technologies, Inc.
19.8. Becton, Dickinson and Company
19.9. Bio-Rad Laboratories, Inc.
19.10. Bio-Techne Corporation
19.11. bioMérieux SA
19.12. Boston Scientific Corporation
19.13. Bruker Corporation
19.14. Cardinal Health Inc.
19.15. Danaher Corporation
19.16. F. Hoffmann-La Roche Ltd.
19.17. GE HealthCare Technologies Inc.
19.18. Grifols, S.A.
19.19. Hologic Inc.
19.20. Illumina, Inc.
19.21. Johnson & Johnson Services Inc.
19.22. Konica Minolta, Inc.
19.23. Koninklijke Philips N.V.
19.24. MedMira Inc.
19.25. Medtronic PLC
19.26. Merck KGaA
19.27. Olympus Corporation
19.28. Perkin Elmer, Inc.
19.29. Pfizer Inc.
19.30. Qiagen N.V.
19.31. Quest Diagnostics Incorporated
19.32. Siemens Healthineers AG
19.33. Sysmex Corporation
19.34. Thermo Fisher Scientific, Inc.
19.35. Trivitron Healthcare
List of Figures
FIGURE 1. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PATHOGEN TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY MASS SPECTROMETERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY MASS SPECTROMETERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY MASS SPECTROMETERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY MICROARRAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY MICROARRAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PCR SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PCR SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PCR SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY ANTIGEN DETECTION KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY ANTIGEN DETECTION KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY ANTIGEN DETECTION KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY ELISA KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY ELISA KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY ELISA KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY IMMUNOASSAY KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY IMMUNOASSAY KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY IMMUNOASSAY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PCR KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PCR KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PCR KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BLOOD, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BLOOD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY STOOL, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY STOOL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY STOOL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SWAB, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SWAB, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SWAB, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SWAB, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY NASAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY NASAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY NASAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY RECTAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY RECTAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY RECTAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY THROAT, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY THROAT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY THROAT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY URINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY URINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY URINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY POC TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY POC TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY POC TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BACTERIAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BACTERIAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY FUNGAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY FUNGAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY FUNGAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PARASITIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PARASITIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PARASITIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY HEPATITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY HEPATITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY HEPATITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY HIV, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY HIV, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY HIV, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INFLUENZA, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INFLUENZA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INFLUENZA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BACTERIAL INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BACTERIAL INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BACTERIAL INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BACTERIAL INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY MENINGITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY MENINGITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY MENINGITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PNEUMONIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PNEUMONIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PNEUMONIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TUBERCULOSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TUBERCULOSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TUBERCULOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY FUNGAL INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY FUNGAL INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY FUNGAL INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY ASPERGILLOSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY ASPERGILLOSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY ASPERGILLOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CANDIDIASIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CANDIDIASIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CANDIDIASIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CRYPTOCOCCOSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CRYPTOCOCCOSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CRYPTOCOCCOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PARASITIC INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PARASITIC INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PARASITIC INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY LEISHMANIASIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY LEISHMANIASIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY LEISHMANIASIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY MALARIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY MALARIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY MALARIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SCHISTOSOMIASIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SCHISTOSOMIASIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SCHISTOSOMIASIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VECTOR-BORNE INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VECTOR-BORNE INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VECTOR-BORNE INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VECTOR-BORNE INFECTIONS, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY DENGUE FEVER, BY REGION, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY DENGUE FEVER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY DENGUE FEVER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY LYME DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY LYME DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY LYME DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY ZIKA VIRUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY ZIKA VIRUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY ZIKA VIRUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY HEPATITIS (A, B, C), BY REGION, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY HEPATITIS (A, B, C), BY GROUP, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY HEPATITIS (A, B, C), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY HEPATITIS B & C, BY REGION, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY HEPATITIS B & C, BY GROUP, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY HEPATITIS B & C, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY HIV/AIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY HIV/AIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY HIV/AIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INFLUENZA, BY REGION, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INFLUENZA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INFLUENZA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 166. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 169. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 171. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 172. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 173. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 174. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 175. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 176. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SWAB, 2018-2032 (USD MILLION)
TABLE 177. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 178. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 179. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL, 2018-2032 (USD MILLION)
TABLE 180. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 181. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BACTERIAL INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 182. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 183. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
TABLE 184. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VECTOR-BORNE INFECTIONS, 2018-2032 (USD MILLION)
TABLE 185. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 186. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 187. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 188. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 189. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 190. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 191. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 192. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SWAB, 2018-2032 (USD MILLION)
TABLE 193. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 194. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 195. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL, 2018-2032 (USD MILLION)
TABLE 196. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 197. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BACTERIAL INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 198. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 199. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
TABLE 200. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VECTOR-BORNE INFECTIONS, 2018-2032 (USD MILLION)
TABLE 201. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 202. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 203. LATIN AMERICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 204. LATIN AMERICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 205. LATIN AMERICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 206. LATIN AMERICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 207. LATIN AMERICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 208. LATIN AMERICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SWAB, 2018-2032 (USD MILLION)
TABLE 209. LATIN AMERICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 210. LATIN AMERICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 211. LATIN AMERICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL, 2018-2032 (USD MILLION)
TABLE 212. LATIN AMERICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 213. LATIN AMERICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BACTERIAL INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 214. LATIN AMERICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 215. LATIN AMERICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
TABLE 216. LATIN AMERICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VECTOR-BORNE INFECTIONS, 2018-2032 (USD MILLION)
TABLE 217. LATIN AMERICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 218. LATIN AMERICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SWAB, 2018-2032 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL, 2018-2032 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BACTERIAL INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VECTOR-BORNE INFECTIONS, 2018-2032 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 235. EUROPE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 236. EUROPE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 237. EUROPE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 238. EUROPE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 239. EUROPE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 240. EUROPE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SWAB, 2018-2032 (USD MILLION)
TABLE 241. EUROPE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 242. EUROPE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 243. EUROPE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL, 2018-2032 (USD MILLION)
TABLE 244. EUROPE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 245. EUROPE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BACTERIAL INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 246. EUROPE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 247. EUROPE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
TABLE 248. EUROPE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VECTOR-BORNE INFECTIONS, 2018-2032 (USD MILLION)
TABLE 249. EUROPE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 250. EUROPE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 251. MIDDLE EAST INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 252. MIDDLE EAST INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 253. MIDDLE EAST INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 254. MIDDLE EAST INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 255. MIDDLE EAST INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 256. MIDDLE EAST INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SWAB, 2018-2032 (USD MILLION)
TABLE 257. MIDDLE EAST INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 258. MIDDLE EAST INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 259. MIDDLE EAST INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL, 2018-2032 (USD MILLION)
TABLE 260. MIDDLE EAST INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 261. MIDDLE EAST INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BACTERIAL INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 262. MIDDLE EAST INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 263. MIDDLE EAST INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
TABLE 264. MIDDLE EAST INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VECTOR-BORNE INFECTIONS, 2018-2032 (USD MILLION)
TABLE 265. MIDDLE EAST INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 266. MIDDLE EAST INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 267. AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 268. AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 269. AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 270. AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 271. AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 272. AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SWAB, 2018-2032 (USD MILLION)
TABLE 273. AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 274. AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 275. AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL, 2018-2032 (USD MILLION)
TABLE 276. AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 277. AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BACTERIAL INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 278. AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 279. AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
TABLE 280. AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VECTOR-BORNE INFECTIONS, 2018-2032 (USD MILLION)
TABLE 281. AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 282. AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 283. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 284. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 285. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 286. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 287. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 288. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SWAB, 2018-2032 (USD MILLION)
TABLE 289. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2032 (USD MILLION)
TABLE 290. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PATHOGEN TYPE, 2018-2032 (USD MILLION)
TABLE 291. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL, 2018-2032 (USD MILLION)
TABLE 292. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 293. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BACTERIAL INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 294. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2032 (USD MILLION)
TABLE 295. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2032 (USD MILLION)
TABLE 296. ASIA-PACIFIC INFECTIOUS DIS

Companies Mentioned

The key companies profiled in this Infectious Disease Diagnostic market report include:
  • Abbott Laboratories
  • Adaptive Biotechnologies Corporation
  • Agilent Technologies, Inc.
  • Amgen Inc.
  • Astellas Pharma Inc.
  • Bausch Health Companies Inc.
  • Becton, Dickinson and Company
  • Bharat Biotech Ltd.
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • bioMérieux SA
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Bristol-Myers Squibb Company
  • Bruker Corporation
  • C.H. Boehringer Sohn AG & Co. KG
  • Cardinal Health Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • GE HealthCare Technologies Inc.
  • GlaxoSmithKline PLC
  • Grifols, S.A.
  • Halma PLC
  • Hologic Inc.
  • Illumina, Inc.
  • Johnson & Johnson Services Inc.
  • Konica Minolta, Inc.
  • Koninklijke Philips N.V.
  • MedMira Inc.
  • Medtronic PLC
  • Merck KGaA
  • Novartis AG
  • Olympus Corporation
  • Perkin Elmer, Inc.
  • Pfizer Inc.
  • Qiagen N.V.
  • Quest Diagnostics Incorporated
  • Sanofi S.A.
  • Siemens Healthineers AG
  • Sun Pharmaceutical Industries Limited
  • Sysmex Corporation
  • Teleflex Incorporated
  • Teva Pharmaceutical Industries Ltd.
  • Thermo Fisher Scientific, Inc.
  • Trivitron Healthcare

Table Information

Report AttributeDetails
No. of Pages186
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 29.41 Billion
Forecasted Market Value ( USD ) by 2032 $ 49.28 Billion
Compound Annual Growth Rate8.9%
Regions CoveredGlobal
No. of Companies Mentioned46

Related Topics

Related Reports

North America Infectious Disease Diagnostics Market Forecast to 2030 - Regional Analysis - By Product, Technology, Application Type, Testing Type, and End User - Product Image

North America Infectious Disease Diagnostics Market Forecast to 2030 - Regional Analysis - By Product, Technology, Application Type, Testing Type, and End User

  • Report
  • 115 Pages
  • North America
From
Asia Pacific Infectious Disease Diagnostics Market Forecast to 2030 - Regional Analysis - By Product, Technology, Application Type, Testing Type, and End User - Product Image

Asia Pacific Infectious Disease Diagnostics Market Forecast to 2030 - Regional Analysis - By Product, Technology, Application Type, Testing Type, and End User

  • Report
  • 136 Pages
  • Asia Pacific
From
Infectious Disease Diagnostics - Global Strategic Business Report - Product Image

Infectious Disease Diagnostics - Global Strategic Business Report

  • Report
  • 259 Pages
  • Global
From
Infectious Diseases In-Vitro Diagnostics Market - Global Forecast 2026-2032 - Product Image

Infectious Diseases In-Vitro Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Healthcare-associated Infectious Disease Diagnostics Market - Global Forecast 2026-2032 - Product Image

Healthcare-associated Infectious Disease Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From

About the Infectious Disease Testing Market

The Infectious Disease Testing market is a sector of the healthcare industry that focuses on the diagnosis and treatment of infectious diseases. It includes a range of tests, such as blood tests, urine tests, and swab tests, to detect the presence of a pathogen. These tests are used to diagnose a wide range of infectious diseases, including HIV, hepatitis, and tuberculosis. The Infectious Disease Testing market is driven by the increasing prevalence of infectious diseases, the growing demand for rapid and accurate diagnosis, and the development of new technologies. Companies in this market are developing innovative tests and technologies to improve the accuracy and speed of diagnosis. Some of the major companies in the Infectious Disease Testing market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. These companies are investing in research and development to develop new tests and technologies to improve the accuracy and speed of diagnosis. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.